CIT Safety & Health Research Lab has acquired the assets of LAB Research Inc.
April 2011 — CIT Safety & Health Research Laboratories (CIT) has acquired all the assets of LAB Research Inc.
CIT is part of the holding company Applied Biology Company (ABC). Through this acquisition, the newly created CIT-LAB group becomes one of the top five preclinical CROs. CIT is an established player in the field of preclinical contract research with more than forty years of experience.
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petrochemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in Canada, Denmark and Hungary.
Our role in the transaction
Oaklins' team in Canada advised the buyer in this transaction.
Contacter l'équipe de la transaction
Transactions connexes
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
En apprendre plusBischoff & Bischoff has acquired Trendmobil
Bischoff & Bischoff Medizin- und Rehabilitationstechnik GmbH, a portfolio company of Lafayette Mittelstand Capital, has acquired Trendmobil GmbH as a strategic add-on.
En apprendre plusClinic DPC has been acquired by Meliva
Meliva has acquired 100% of Lithuanian dental care provider Clinic DPC from United Clinics. The transaction further strengthens Meliva’s dental care offering and represents another step in its strategy to expand its presence in the Lithuanian private healthcare market.
En apprendre plus